MorphoSys AG (MOR)
17.89
+0.38
(+2.17%)
USD |
NASDAQ |
May 02, 16:00
17.89
0.00 (0.00%)
After-Hours: 19:19
MorphoSys Accounts Receivable (Quarterly): 35.48M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 35.48M |
June 30, 2023 | 77.45M |
March 31, 2023 | 68.61M |
December 31, 2022 | 97.84M |
June 30, 2022 | 125.83M |
March 31, 2022 | 82.70M |
December 31, 2021 | 85.95M |
September 30, 2021 | 89.36M |
March 31, 2021 | 118.75M |
December 31, 2020 | 102.52M |
September 30, 2020 | 37.06M |
June 30, 2020 | 37.23M |
March 31, 2020 | 28.49M |
December 31, 2019 | 16.89M |
September 30, 2019 | 18.97M |
June 30, 2019 | 22.06M |
March 31, 2019 | 22.86M |
December 31, 2018 | 20.28M |
September 30, 2018 | 16.49M |
June 30, 2018 | 13.57M |
March 31, 2018 | 15.98M |
December 31, 2017 | 13.48M |
September 30, 2017 | 11.77M |
June 30, 2017 | 15.54M |
March 31, 2017 | 11.55M |
Date | Value |
---|---|
December 31, 2016 | 13.32M |
September 30, 2016 | 10.80M |
June 30, 2016 | 12.95M |
March 31, 2016 | 11.38M |
December 31, 2015 | 12.51M |
September 30, 2015 | 11.54M |
June 30, 2015 | 13.21M |
March 31, 2015 | 18.02M |
December 31, 2014 | 18.23M |
September 30, 2014 | 17.06M |
June 30, 2014 | 19.34M |
March 31, 2014 | 13.54M |
December 31, 2013 | 14.18M |
September 30, 2013 | 12.83M |
June 30, 2013 | 38.63M |
March 31, 2013 | 10.47M |
December 31, 2012 | 11.80M |
September 30, 2012 | 11.67M |
June 30, 2012 | 13.57M |
March 31, 2012 | 13.65M |
December 31, 2011 | 15.81M |
September 30, 2011 | 15.71M |
June 30, 2011 | 17.37M |
March 31, 2011 | 54.26M |
December 31, 2010 | 19.96M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
16.89M
Minimum
Dec 2019
125.83M
Maximum
Jun 2022
65.32M
Average
73.03M
Median
Accounts Receivable (Quarterly) Benchmarks
Incyte Corp | 745.53M |
Novartis AG | 7.84B |
Immatics NV | 4.524M |
Affimed NV | 5.888M |
InflaRx NV | -- |